1. Oba MS, Murakami Y, Nishiwaki Y, Asakura K, Ohfuji S, Fukushima W, et al. Estimated prevalence of Cronkhite-Canada syndrome, chronic enteropathy associated with SLCO2A1 gene, and intestinal Behcet’s disease in Japan in 2017: a nationwide survey. J Epidemiol. 2021 Feb 5;31(2):139–44.
2. Fan RY, Wang XW, Xue LJ, An R, Sheng JQ. Cronkhite-Canada syndrome polyps infiltrated with IgG4-positive plasma cells. World J Clin Cases. 2016 Aug;4(8):248–52.
3. Sweetser S, Ahlquist DA, Osborn NK, Sanderson SO, Smyrk TC, Chari ST, et al. Clinicopathologic features and treatment outcomes in Cronkhite-Canada syndrome: support for autoimmunity. Dig Dis Sci. 2012 Feb;57(2):496–502.
4. Daniel ES, Ludwig SL, Lewin KJ, Ruprecht RM, Rajacich GM, Schwabe AD. The Cronkhite-Canada syndrome. An analysis of clinical and pathologic features and therapy in 55 patients. Medicine. 1982 Sep;61(5):293–309.
5. Watanabe C, Komoto S, Tomita K, Hokari R, Tanaka M, Hirata I, et al. Endoscopic and clinical evaluation of treatment and prognosis of Cronkhite-Canada syndrome: a Japanese nationwide survey. J Gastroenterol. 2016 Apr;51(4):327–36.